CAR-T Deal: Hemogenyx signed a definitive collaboration with Cellin Technologies to manufacture and implement its HG-CT-1 CAR-T for relapsed/refractory AML in Estonia under the hospital exemption pathway. Whole-Body MRI Backlash: Radiologists and other clinicians criticized neuroscientist podcaster Andrew Huberman’s push for whole-body MRI screening in healthy people, citing lack of recommendations and risks from false positives. Radiation Safety Support: UAB researchers are building TheraGuide, a digital tool to help patients follow radiation safety precautions after radiopharmaceutical therapy. Vaccine Policy Fight: Trump’s executive order urges fewer childhood vaccines and separate MMR shots, drawing medical concern and criticism from health officials. TB Medicine Shortages: In the Philippines, MSF says recurring TB drug stock-outs are forcing patients to buy medicines privately, raising costs and risking resistance. Pharma Legal Fallout: Veloxis Pharmaceuticals will resolve U.S. kickback allegations tied to Envarsus XR with a deferred prosecution agreement and $46M+ payment. Medical Devices Law Push: India’s medtech groups want a standalone medical device law, arguing a draft bill is too pharma-focused. Healthcare Access Gaps: Rangpur Medical College Hospital in Bangladesh faces an ICU bed shortage, with critical patients waiting for limited capacity. Public Health in War: WHO says a Dnipro humanitarian medical warehouse was destroyed in strikes, wiping supplies meant for hundreds of thousands. Rural Training Recognition: Australia’s rural generalist training programs gained accreditation, setting a pathway toward specialist recognition.